Draganfly Inc. (NASDAQ:DPRO – Free Report) – Stock analysts at HC Wainwright issued their FY2028 earnings per share (EPS) estimates for shares of Draganfly in a research report issued on Wednesday, August 12th. HC Wainwright analyst A. Dayal forecasts that the company will post earnings of ($1.69) per share for the year. HC Wainwright currently […]

Surf Air Mobility Inc. (NYSE:SRFM – Free Report) – Research analysts at HC Wainwright boosted their Q3 2026 earnings per share (EPS) estimates for shares of Surf Air Mobility in a research note issued to investors on Tuesday, August 11th. HC Wainwright analyst A. Dayal now expects that the company will post earnings of ($0.11) […]

Travere Therapeutics, Inc. (NASDAQ:TVTX – Free Report) – Research analysts at HC Wainwright lifted their Q3 2026 EPS estimates for shares of Travere Therapeutics in a report released on Wednesday, August 5th. HC Wainwright analyst J. Pantginis now anticipates that the company will post earnings of $0.10 per share for the quarter, up from their […]

Oculis Holding AG (NASDAQ:OCS – Free Report) – HC Wainwright lowered their Q3 2026 EPS estimates for shares of Oculis in a note issued to investors on Monday, August 10th. HC Wainwright analyst Y. Chen now expects that the company will post earnings of ($0.48) per share for the quarter, down from their prior forecast […]

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) – Investment analysts at HC Wainwright raised their Q3 2026 earnings per share (EPS) estimates for shares of Mirum Pharmaceuticals in a research note issued on Thursday, August 6th. HC Wainwright analyst S. Ramakanth now forecasts that the company will earn ($0.31) per share for the quarter, up […]

Immuneering Corporation (NASDAQ:IMRX – Free Report) – Equities research analysts at HC Wainwright issued their Q3 2026 EPS estimates for Immuneering in a research note issued to investors on Thursday, August 6th. HC Wainwright analyst A. Maldonado anticipates that the company will post earnings per share of ($0.31) for the quarter. HC Wainwright has a […]

Viridian Therapeutics, Inc. (NASDAQ:VRDN – Free Report) – Analysts at HC Wainwright reduced their Q3 2026 earnings per share estimates for shares of Viridian Therapeutics in a report released on Thursday, August 6th. HC Wainwright analyst D. Tsao now anticipates that the company will earn ($1.13) per share for the quarter, down from their previous […]

First Majestic Silver Corp. (NYSE:AG – Free Report) (TSE:FR) – Research analysts at HC Wainwright lifted their FY2026 earnings per share estimates for shares of First Majestic Silver in a note issued to investors on Friday, July 31st. HC Wainwright analyst H. Ihle now forecasts that the mining company will post earnings per share of […]